Industry Focus

The Motley Fool discusses how investors might want to think about Valeant Pharmaceuticals' share price tailspin and marijuana drugmaker GW Pharmaceuticals' skyrocketing valuation.

Direct download: 160323_IF_Healthcare.mp3
Category:Podcast -- posted at: 5:21pm EST